Structure-function studies of the HIV-1 coreceptors

Seminars in Immunology

Volumn 10, Issue 3, 1998, Pages 237-248

  Berson, Joanne F ^b   Doms, Robert W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Civic Center Blvd ^*  (United States)

Author keywords

CCR5; CXCR4; Envelope; HIV; Structure function

Indexed keywords

CHEMOKINE; ENVELOPE PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; VIRUS RECEPTOR;

ARTICLE; CELL FUSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INTERNALIZATION; NONHUMAN; PROTEIN DOMAIN; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; VIRUS INFECTION;

EID: 0032103594     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.0130     Document Type: Article

References (77)

1. 1. Berger EA (1997) HIV entry and tropism: the chemokine receptor connection. AIDS 11 Suppl A:S3-S16
2. 2. Doms RW, Peiper SC (1997) Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 235:179-190
3. 3. Moore JP, Trkola A, Dragic T (1997) Co-receptors for HIV-1 entry. Curr Opin Immunol 9:551-562
4. 4. Broder CC, Collman RG (1997) Chemokine receptors and HIV. J Leukocyte Biol 62:20-29
5. 5. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996) The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148
6. 6. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158
7. 7. Rucker J, Edinger AL, Sharron M, Samson M, Lee B, Berson JF, Yi Y, Collman RG, Doranz BJ, Parmentier M, Doms RW (1997) Utilization of chemokine receptors, orphan receptors, and herpesvirus encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 71:8999-9007
8. 8. Liao F, Alkhatib G, Peden KWC, Sharma G, Berger EA, Farber JM (1997) STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 185:2015-2023
9. 9. Farzan M, Choe H, Martin K, Marcon L, Hofmann W, Karlsson G, Sun Y, Barrett P, Marchand N, Sullivan N, Gerard N, Gerard C, Sodroski J (1997) Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 186:405-411
10. 10. Deng H, Unutmaz D, Kewalramani VN, Littman DR (1997) Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296-300
11. 11. Pleskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M (1997) Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276:1874-1878
12. 12. Reeves JD, McKnight A, Potempa S, Simmons G, Gray PW, Power CA, Wells T, Weiss RA, Talbot SJ (1997) CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 231:130-134
13. 13. Zhang L, Huang Y, He T, Cao Y, Ho DD (1996) HIV-1 subtype and second-receptor use. Nature 383:768
14. 14. Simmons G, Wilkinson D, Reeves JD, Dittman MT, Beddows S, Weber J, Carnegis G, Gesselberger U, Gray PW, Weiss RA, Clapham PR (1996) Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 70:8355-8360
15. 15. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645-649
16. 16. DeJong J-J, Goudsmit J, Keulen W, Klaver B, Krone W, Tersmette M, deRonde A (1992) Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 66:757-765
17. 17. Fouchier RAM, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H (1992) Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 66:3183-3187
18. 18. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR (1991) Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71-74
19. 19. Liu Z-Q, Wood C, Levy JA, Cheng-Mayer C (1990) The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue. J Virol 67:6148-6153
20. 20. O'Brien WA, Koyanagi Y, Namazie A, Zhao J-Q, Diagne A, Idler K, Zack JA, Chen ISY (1990) HIV-tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348:69-73
21. 21. Shioda T, Levy JA, Cheng-Meyer C (1991) Macrophage and T-cell line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349:167-169
22. 22. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, Gerard C, Sodroski J (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183
23. 23. Trkola A, Drajic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ, Moore JP (1996) CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5. Nature 384:184-187
24. 24. Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H (1996) Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274:602-605
25. 25. Hesselgesser J, Halks-Miller M, DelVecchio V, Peiper SC, Hoxie J, Kolson DL, Taub D, Horuk R (1997) CD4-independent association between HIV-1 gp120 and CXCR4: Functional chemokine receptors are expressed in human neurons. Curr Biol 7:112-121
26. 26. Hill CM, Deng H, Unutmaz D, Kewalramani VN, Bastiani L, Gorny MK, Zolla-Pazner S, Littman DR (1997) Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodefiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J Virol 71:6296-6304
27. 27. Tachibana K, Nakajima T, Sato A, Igarashi K, Shida H, Iizasa H, Yoshida N, Yoshie O, Kishimoto T, Nagasawa T (1997) CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry. J Exp Med 185:1865-1870
28. 28. Bieniasz PD, Fridell RA, Aramori I, Ferguson SSG, Caron MG, Cullen BR (1997) HIV-1 induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 coreceptor. EMBO J 16:2599-2609
29. 29. Lu Z, Berson JF, Chen Y, Tumer JD, Zhang T, Sharron M, Jenks MH, Wang Z, Kim J, Rucker J, Hoxie JA, Peiper SC, Doms RW (1997) Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc Natl Acad Sci USA 94:6426-6431
30. 30. Pleskoff O, Sol N, Labrosse B, Alizon M (1997) Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (Fusin). J Virol 71:3259-3262
31. 31. Willett BJ, Picard L, Hosie MJ, Turner JD, Adema K, Clapham PR (1997) Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol 71:6407-6415
32. 32. Chen Z, Zhou P, Ho DD, Landau NR, Marx PA (1997) Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 71:2705-2714
33. 33. Edinger AL, Amedee A, Miller K, Doranz BJ, Endres M, Sharron M, Samson M, Lu Z-H, Clements JE, Murphey-Corb M, Peiper SC, Parmentier M, Broder CC, Doms RW (1997) Differential utilization of CCR5 by macrophage and T-cell tropic SIV strains. Proc Natl Acad Sci USA 94:4005-4010
34. 34. Brelot A, Heveker N, Pleskoff O, Sol N, Alizon M (1997) Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J Virol 71:4744-4751
35. 35. Ashorn PA, Berger EA, Moss B (1990) Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J Virol 64:2149-2156
36. 36. Clapham PR, Blanc D, Weiss RA (1991) Specific cell surface requirements for infection of CD4-positive cells by human immunodeficiency virus type 1, type 2 and simian immunodeficiency virus. Virology 181:703-715
37. 37. Lorès P, Boucher V, Mackay C, Pla M, Boehmer HV, Jami J, Barre-Sinoussi F, Weill J-C (1992) Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection. AIDS Res Hum Retroviruses 8:2063-2071
38. 38. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-385
39. 39. Picard L, Wilkinson DA, McKnight A, Gray PW, Hoxie JA, Clapham PR, Weiss RA (1997) Role of the amino-terminal extracellular domain of CXCR4 in human immunodeficiency virus type 1 entry. Virology 231:105-111
40. 40. McKnight A, Wilkinson D, Simmons G, Talbot S, Picard L, Ahuja M, Marsh M, Hoxie JA, Clapham PR (1997) Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol 71:1692-1696
41. 41. Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty BS, Choe PJV, Wells TNC, Power CA, Sutterwala SS, Doms RW, Landau NR, Hoxie JA (1996) CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745-765
42. 42. Speck RF, Wehrly K, Platt EJ, Atchison RE, Charo IF, Kabat D, Chesebro B, Goldsmith MA (1997) Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol 71:7136-7139
43. 43. Berson JF, Long D, Doranz BJ, Rucker J, Jirik FR, Doms RW (1996) A seven transmembrane domain receptor involved in fusion and entry of T-cell tropic human immunodeficiency virus type-1 strains. J Virol 70:6288-6295
44. 44. Potempa S, Picard L, Reeves JD, Wilkinson D, Weiss RA, Talbot SJ (1997) CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR4 in fusion and entry. J Virol 71:4419-4424
45. 45. Reeves JD, Schulz TF (1997) The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion. J Virol 71:1453-1465
46. 46. Atchison RE, Gosling J, Monteclaro FS, Franci C, Digilio L, Charo IF, Goldsmith M (1996) Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274:1924-1926
47. 47. Doranz BJ, Lu Z, Rucker J, Zhang T, Sharron M, Cen Y, Wang Z, Guo H, Du J, Accavitti MA, Doms RW, Peiper SC (1997) Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J Virol 71:6305-6314
48. 48. Picard L, Simmons G, Power CA, Meyer A, Weiss RA Clapham PR (1997) Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J Virol 71:5003-5011
49. 49. Rucker J, Samson M, Doranz BJ, Libert F, Berson J, Yi Y, Collman RG, Vassart G, Broder CC, Doms RW, Parmentier M (1996) Region s in β-chemokine receptors CKR-5 and CKR-2b that determine HIV-1 cofactor specificity. Cell 87:437-446
50. 50. Alkhatib G, Ahuja SS, Light D, Mummidi S, Berger EA, Ahuja SK (1997) CC chemokine receptor 5-mediated signaling and HIV-1 co-receptor activity share common structural determinants. J Biol Chem 272:19771-19776
51. 51. Ross TM, Bieniasz PD, Cullen BR (1998) Multiple residues contribute to the inability of murine CCR5 to function as a co-receptor for macrophage-tropic HIV-1 isolates. J Virol 72:1918-1924
52. 52. Schall TJ, Bacon KB (1994) Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6:865-873
53. 53. Clements JE, Zink MC (1996) Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev 9:100-117
54. 54. Mori K, Ringler DJ, Desrosiers RC (1993) Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by Env but is not due to restricted entry. J Virol 67:2807-2814
55. 55. Chackerian B, Long EM, Luciw PA, Overbaugh J (1997) Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 71:3932-3939
56. 56. Edinger AL, Mankowski JL, Doranz BJ, Margulies BJ, Lee B, Rucker J, Sharron M, Hoffman TL, Berson JF, Zink MC, Hirsch VM, Clements JE, Doms RW (1998) CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by neurovirulent SIV. Proc Natl Acad Sci USA, 94:14742-14747
57. 57. Alkhatib G, Berger EA, Murphy PM, Pease JE (1997) Determinants of HIV-1 coreceptor function on CC Chemokine Receptor 3. J Biol Chem 272:20420-20426
58. 58. Premack BA, Schall TJ (1996) Chemokine receptors: gateways to inflammation and infection. Nat Med 2:1174-1178
59. 59. Alkhatib G, Locati M, Kennedy PE, Murphy PM, Berger EA (1997) HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 234:340-348
60. 60. Farzan M, Choe H, Martin KA, Sun Y, Sidelko M, Mackay CR, Gerard NP, Sodroski J, Gerard C (1997) HIV-1 entry and macrophage inflammatory protein 1 β-mediated signaling are independent functions of the chemokine receptor CCR5. J Biol Chem 272:6854-6857
61. 61. Aramori I, Zhang J, Ferguson SSG, Bieniasz PD, Cullen BR, Caron MG (1997) Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J 16:4606-4616
62. 62. Gosling J, Monteclaro FS, Atchison RE, Arai H, Tsou C, Goldsmith MA, Charo IF (1997) Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc Natl Acad Sci USA 94:5061-5066
63. 63. Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P (1996) The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med 2:1244-1247
64. 64. Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TNC, Proudfoot WEI (1997) Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276:276-279
65. 65. Arenzana-Seisdedos F, Virelizier J-L, Rousset D, dark-Lewis I, Loetscher P, Moser B, Baggiolini M (1996) HIV blocked by chemokine antagonist. Nature 383:400
66. + T cells. Science 270:1811-1815
67. 67. Trkola A, Paxton WA, Monard SP, Hoxie JA, Siani MA, Thompson DA, Wu L, Mackay CR, Horuk R, Moore JP (1998) Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC-chemokines. J Virol 72:396-404
68. 68. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Luttichau HR, Gerstoft J, Clapham PR, Clark-Lewis I, Wells TNC, Schwartz TW (1997) A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277:1656-1659
69. 69. O'Brien WA, Sumner-Smith M, Mao S-H, Sadeghi S, Zhao J-Q, Chen ISY (1996) Antihuman immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions. J Virol 70:2825-2831
70. 70. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane domain, G protein-coupled receptor. Science 272:872-877
71. 71. Doranz BJ, Grovit-Ferbasi K, Sharron MP, Mao S-H, Goetz MB, Daar ES, Doms RW, O'Brien WA (1997) A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 186:1395-1400
72. 72. Murakami T, Nakajima T, Koyanagi Y, Tachibana K, Fujii N, Tamamura H, Yoshida N, Waki M, Matsumoto A, Yoshie O, Kishimoto T, Yamamoto N, Nagasawa T (1997) A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med 186:1389-1393
73. 73. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, Clercq ED, Moore JP (1998) AMD3100, a small molecule that interacts with the CXCR4 co-receptor to prevent HIV-1 entry. Nat Med 4:72-77
74. 74. Schols D, Struyf S, Damme JV, Este JA, Henson G, Clercq ED (1997) Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 186:1383-1388
75. 75. Cho MW, Lee MK, Carney MC, Berson JF, Doms RW, Martin MA (1998) Identification of determinants on a dual-tropic human immunodeficiency virus type-1 envelope glycoprotein that confer usage of CXCR4. J Virol 72:2509-2515
76. 76. Verrier FC, Charneau P, Altmeyer R, Laurent S, Borman AM, Girard M (1997) Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate. Proc Natl Acad Sci USA 94:9326-9331
77. 77. Binley J, Moore JP (1997) The viral mousetrap. Nature 387:346-348